Cambium Bio (ASX:CMB) - Key People
ASX:CMB · Directors, executives and key personnel · 12 month lookback
Karolis Rosickas, MS
Current
Chief Executive Officer
No articles mention this person in the last 12 months.
Mentioned in
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Cambium Bio Advances Elate Ocular Phase 3 Trial with FDA Single Pivotal Study Pathway amid AUD 4.1M Loss
28 Aug 2026
Healthcare Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
Cambium Bio Secures A$1 Million Placement at Premium to Fund Phase 3 Trial
22 July 2026
Also Mentioned
People named in Cambium Bio (ASX:CMB) articles over the last 12 months, by frequency.
Sebastian Tseng
· 10 articles
Edmund K. Waller
· 4 articles
Terence A. Walts
· 4 articles
Chi-Tai Chang
· 4 articles
Chandra Bala
· 4 articles
Denese Marks
· 4 articles
Li-Chien Chiu
· 4 articles
Samir Tirodkar
· 4 articles
Vinay Prasad
· 3 articles
Martin Makary
· 3 articles
Chun Yi Wu
· 2 articles
Brandon Wu
· 2 articles
Mark Licciardo
· 2 articles
Bernard Tannoury
· 1 article